CLINICAL_TRIALS
research
· 2025-05-14
Clinical Trial Update: A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Summary
An ongoing University of Chicago study aims to characterize the natural progression of interstitial lung diseases. The study includes idiopathic pulmonary fibro…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Chicago | Conditions: Interstitial Lung Diseases, Idiopathic Pulmonary Fibrosis | Status: RECRUITING